CA2003842C - Topical composition - Google Patents

Topical composition

Info

Publication number
CA2003842C
CA2003842C CA002003842A CA2003842A CA2003842C CA 2003842 C CA2003842 C CA 2003842C CA 002003842 A CA002003842 A CA 002003842A CA 2003842 A CA2003842 A CA 2003842A CA 2003842 C CA2003842 C CA 2003842C
Authority
CA
Canada
Prior art keywords
phosphate
mono
composition according
chosen
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002003842A
Other languages
French (fr)
Other versions
CA2003842A1 (en
Inventor
David Howard Birtwistle
Peter Carter
David Arthur Rosser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Original Assignee
Unilever PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever PLC filed Critical Unilever PLC
Publication of CA2003842A1 publication Critical patent/CA2003842A1/en
Application granted granted Critical
Publication of CA2003842C publication Critical patent/CA2003842C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/556Derivatives containing from 2 to 10 oxyalkylene groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/02Preparations for cleaning the hair

Abstract

A composition suitable for topical application to the skin or hair, comprises:

a. a dialkyl or dialkenyl phosphate salt having the structure (1):

(1) and b. a branched or unbranched, monoalkyl or monoalkenyl phosphate salt (or mixtures thereof) having the structure (2):

( 2) where R01, R02 and R03 are each chosen from branched or unbranched, alkyl or alkenyl groups having an average of from 7 to 9 carbon atoms;

X, Y and Z are each chosen from H, alkali metal, ammonium and substituted ammonium counterions;
and a, b and c are each chosen from 0 or a value of from 1 to 4;

the weight ratio of the monoalkyl or monoalkenyl phosphate salt to the dialkyl or dialkenyl phosphate salt being from 1:1000 to 1:5.

Description

;~003~42 -- 1 - J,3091 TOPICAL COMPOSITION

FIELD OF THE INVENTION

The invention relates to compositions suitable for topical application to the skin, (including the mucosae), and to the hair. In particular, the invention is concerned with highly improved detergent compositions suitable for cleansing the whole body surface, including the mouth.

BACKGROUND TO THE INVENTION & PRIOR ART

The damaging effect of conventional detergents used to wash the body surface, particularly where young, tender or damaged skin is involved, has been the subject of intense study for many years in a search for milder-to-the-skin products, which not only cleanse the skin efficiently, but also leave the skin with a pleasant smooth silky feel after the skin surface has been dried off.
The use of certain mono- and di-alkyl phosphate salts for this purpose has been advocated in view of their mild characteristics, but some of this group of salts are used 2003~342
- 2 - J,3091 as antifoam agents because of their lather suppressant properties, and would therefore require careful formulation if lather control is not required.

To this end, US patent No. 4,139,485 (Kao Soap Co.
Ltd.) describes a detergent composition having low irritation properties on human skin, wherein the surfactant component is dialkyl or dialkenyl phosphate salt (DAP) and/or monoalkyl or monoalkenyl phosphate salt (MAP), each alkyl or alkenyl group having from 10 to 16 carbon atoms), the weight ratio of 'DAP' to 'MAP' being ~rom 20:80 to 0:100. This system is stated to possess good detergency.

Also, US patent No. 4,526,710 (Kao Corporation), report a study to improve properties of detergent composition which make use of anionic phosphate surface active agents, which Kao maintain are highly innoxious and particularly mild to the skin. As a result, Kao have found that when phosphate ester salts having a specific ion pair, notably mono- or di-alkyl (C8-18) phosphates, are used in combination with alkanol amine salts of higher fatty acids and alkyl amine oxides, the detergency and foaming characteristics are remarkably improved.
~5 - Also, US patent No. 4,758,376 (Kao) discloses an alternative composition, comprising an alkanolamine salt of a mono or dialkyl (C8-18) phosphate or mixtures thereof, to that described in US patent No. 4,526,710 in 30 which the problem of poor foaming due to the dialkyl phosphate salt is dealt with by incorporating with the phosphate a compound chosen from an amidoamine amphoteric surfactant or hydroxysulphobetaine, or an aliphatic lactylate or glycolate.

;~00~84:~
- 3 - J,3091 It is clear from a study of the three Kao references, that all the evidence on which their disclosures are based is restricted to alkyl phosphates or dialkyl phosphates in which the alkyl group has at least 10 carbon atoms. There is absolutely no reference at all to any evaluation of an alkyl phosphate ester or dialkyl phosphate ester salt where the alkyl group or groups contains only 9 carbon atoms, or less.

Applicants in their search for a mild surfactant for use in cleansing human skin or hair, with the added attribute that a full, soft lather is produced without necessarily incorporating a secondary surfactant such as those proposed by Kao, have unexpectedly discovered that certain dioctyl phosphate salts meet their requirements in this respect. Furthermore, even higher lather volumes can be produced when the amount to be incorporated in such formulations of the corresponding monooctyl phosphate salt, which usually contaminates commercially available dioctyl phosphate salt, is reduced to a lower than usual level. The compositions so obtained are accordingly capable of producing a superior lather volume and an outstanding lather creaminess. Also, the composition is so mild to the skin that it can safely be used for cleansing the mucosae, such as the mouth and the vagina, and other more delicate skin areas. It can also be used in shampoos for frequent, e.g. daily, hair washing, without risk of scalp irritation or damage attributable to harsher products. In addition to these excellent attri~utes, the ease of rinsing from hair or skin and superior silky-smooth after-use skin feel properties of the compositions, including freedom from skin roughness and erythema, have great consumer appeal.

2003~42
- 4 - J,3091 DEFINITION OF THE INVENTION

Accordingly, the invention provides a composition suitable for topical application to the skin or hair, which comprises:

(a) from 1 to 99.9% by weight of a dialkyl or dialkenyl phosphate salt (or mixtures thereof) having the structure (1):
o (O 2C 2)a \ ~
P--OX
(OC 2C 2)b (b) from 0.01 to 10% by weight of a branched or unbranched, monoalkyl or monoalkenyl phosphate salt (or mixtures thereof) having the structure (2):
O OY

R03-(oCH2CH2)Co P (2) OZ

h R01 R02 and R03 are each chosen from branched or unbranched, alkyl or alkenyl groups having an average of from 7 3 0 to 9 carbon atoms;

X, Y and Z are each chosen from H, alkali metal, ammonium and substituted ammonium counterions; and 20C)384~

~ 5 ~ J,3091 a, b and c are each chosen from 0 or a value of from l to 4;

the weight ratio of the monoalkyl or monoalkenyl phosphate salt to the dialkyl or dialkenyl phosphate salt being from 1:1000 to 1:5.

DISCLOSURE OF THE INVENTION

The Dialkyl or Dialkenyl Phosphate Salt The composition according to the invention comprises as a surfactant, a dialkyl or dialkenyl phosphate salt (or mixtures thereof) having the structure:

o (O 2C 2)a \ ~
P OX
R -(OCH2CH2) b-where R01 and R0 2 are each chosen from branched or unbranched alkyl or alkenyl groups having an average of from 7 to 9 carbon atoms;
X is chosen from H, alkali metal ammonium, and substituted ammonium counterions; and a ~ b are each chosen from 0 or a value of from 1 to 4.

Examples of the dialkyl- and dialkenyl phosphate moiety include:

20();~8~

- 6 - J,3091 di-n-heptyl phosphate di-n-octyl phosphate di-n-nonyl phosphate di-(diethyleneglycol-mono-n-nonyl ether) phosphate di-(ethyleneglycol-mono-n-octyl ether) phosphate di-n-heptenyl phosphate di-n-octenyl phosphate di-n-nonenyl phosphate di-(triethyleneglycol-mono-n-octenyl ether) phosphate di-(ethyleneglycol-mono-n-heptyl ether) phosphate di-(7-methyloctyl) phosphate di-(5-methylhexyl) phosphate di-(6,6-dimethylheptyl) phosphate n-hexyl-n-nonyl phosphate, and n-hexyl-n-octyl phosphate.

The preferred dialkyl phosphate moiety is di-n-octyl phosphate, and the preferred counterion is chosen from sodium, potassium and triethanolammonium.

The amount of dialkyl or dialkenyl phosphate salt which is present in the composition according to the invention is from 1 to 99.9%, preferably from 2 to 50% by weight of the composition.

Compositions containing less than 1% by weight of the dialkyl or dialkenyl phosphate salt show poor lather characteristics and lack the desired feel properties associated with compositions containing higher levels o~

this ingredient.

20();~842 ~ 7 ~ J,3091 The Monoalkyl or Monoalkenyl Phosphate Salt The composition according to the invention also comprises, as a lather modifier, a monoalkyl or monoalkenyl phosphate salt (or mixtures thereof) having the structure (2):

O OY

R -(OCN2CH2)cO - P (2) OZ

where R03 is chosen from branched or unbranched alkyl or alkenyl groups having from 7 to 9 carbon atoms;

Y and Z are each chosen from H, alkali metal, ammonium and substituted ammonium counterions; and c is 0, or an integer of from 1 to 4.

Examples of the monoalkyl and monoalkenyl phosphate moiety include:

mono-n-heptyl phosphate mono-n-octyl phosphate mono-n-nonyl phosphate diethyleneglycol-mono-n-nonyl ether phosphate ethyleneglycol-mono-n-octyl ether phosphate mono-n-heptenyl phosphate mono-n-octenyl phosphate mono-n-nonenyl phosphate triethyleneglycol-mono-n-octenyl ether phosphate ethyleneglycol-mono-n-heptenyl ether phosphate mono-7-methyloctyl phosphate 200384~

- 8 - J,3091 mono-5-methylhexyl phosphate mono-6,6-dimethylheptyl phosphate Preferably, the R2 group is the same as the Rl group;
thus when the dialkylphosphate salt is a dioctyl phosphate salt, then the monoalkyl phosphate is preferably a monooctyl phosphate salt.

The amount of the monoalkyl or monoalkenyl phosphate salt which is present in the composition according to the invention is from 0.01 to 20%, preferably from 0.05 to 5%
by weight of the composition.

Compositions containing less than 0.01% by weight of the monoalkyl or monoalkenyl phosphate salt are difficult to prepare, as the monosalt is difficult to separate entirely from the corresponding di-salt.

The weight ratio of the monoalkyl or monoalkenyl phosphate salt to the dialkyl or dialkenyl phosphate salt is from 1:1000 to 1:5, preferably from 1:1000 to 1:20.

Compositions in which this weight ratio is greater than 1:5 show poor lather characteristics.
The choice of an amount of the monoalkyl or monoalkenyl phosphate salt within the stated range will modify the lather, in terms of its volume and/or creaminess, that the composition is capable of producing.
Evidence is given later in this specification to illustrate how the lather characteristics of the composition can be modified by varying the mono- and di-alkyl or alkenyl:salt ratio.

Water The composition according to the invention also 200~84~2 - 9 - J,3091 comprises an amount of water to act as a vehicle for the dialkyl or dialkenyl phosphate salt and to enable it to be provided at a concentration suitable for convenient topical application to human skin.

The amount of water present in the composition of the invention is accordingly up to 99%, preferably from 5 to 99% by weight of the composition.

Co-surfactant The composition according to the invention can also optionally comprise a co-surfactant, further to modify the surfactant properties attributable to the dialkyl or dialkenyl phosphate salt, and the monoalkyl or monoalkenyl phosphate salt.

Examples of co-surfactants include anionic surfactants other than the phosphate salts defined herein, as well as nonionic, amphoteric and zwitterionic surfactants.

Anionic Co-surfactants Particularly preferred co-surfactants, when employed, are anionic surfactants, examples of which are set out hereinafter.

i. Fatty acid soap co-surfactant The composition according to the invention can optionally comprise, as a co-surfactant one or more soaps which are water-soluble or water-dispersable alkali metal salts of an organic acid, especially a sodium or a potassium salt, or the corresponding ammonium or substituted ammonium salt. Examples of suitable organic acids are natural or synthetic alkanoic acids having from -- 10 - J,3091 10 to 22 carbon atoms, especially the fatty acids of triglyceride oils such as tallow and coconut oil.

For solid products, such as powders, bar or tablets, the preferred soap is a soap of tallow fatty acids, that is fatty acids derived from tallow class fats, for example beef tallow, mutton tallow, lard, palm oil and some vegetable butters. Minor amounts of up to about 30%, preferably 10 to 20~, by weight of sodium soaps of nut oil fatty acids derived from nut oils, for example coconut oil and palm kernel oil, may be admixed with the sodium tallow soaps, to improve their lathering and solubility characteristics if desired. Whereas tallow fatty acids are predominantely C14 and C18 fatty acids, the nut oil fatty acids are of shorter chain length and are predominantly C10-Cl4 fatty acids.

For liquid or gel products, the preferred soaps are y C10_14 ~atty acids derived from nut oils or alternatively, from synthetic alkanoic acids.

The soaps can be provided as a preformed ingredient for the composition, or they can be formed in situ during the manufacture of the composition by reaction of suitable fatty acids and an alkali.

The amount of fatty acid soap which can be present in the composition according to the invention is up to 90%, preferably from 2 to 80% by weight of the composition.
ii. Non-soap anionic co-surfactants The composition according to the invention can also optionally comprise one or more non-soap anionic co-surfactants, examples of which include:

- _ Z003842 - 11 - J,3091 The alkali metal salts of organic sulphuric reaction products having an alkyl or acyl radical containing from 8-22 carbon atoms and a sulphonic acid or sulphuric acid ester group. Specific examples of these synthetic anionic surfactants are the sodium, ammonium, potassium or triethanolammonium alkyl sulphates, especially those obtained by sulphating the higher alcohols (C8-C18), sodium coconut oil fatty acid monoglyceride sulphates and sulphonates; sodium or potassium salts of sulphuric esters of the reaction product of one mole of a higher fatty alcohol (e.g. tallow or coconut oil alcohols) and 1-12 moles of ethyleneoxide; sodium or potassium salts of alkyl phenol ethylene oxide ether sulphate with 1-10 units of ethylene oxide per molecule and in which the alkyl group contains from 8 to 12 carbon atoms, sodium alkyl glyceryl ether sulphonates, the reaction product of fatty acids having from 10 to 22 carbon atoms esterified with isethionic acid and neutralised with sodium hydroxide;
water soluble salts of condensation products of fatty acids with N-methyl taurine.

Especially preferred non-soap anionic co-surfactants include:

alkylaryl sulphonates, such as sodium alkyl benzene sulphonate (e.g. TEEPOL CM44, available from Shell).

alkyl sulphates, such as sodium lauryl sulphate (e.g.
EMPICOL CX, available from Albright & Wilson), and triethanolommonium lauryl sulphate (e.g. EMPICOL TL40/T, available from Albright & Wilson).

alkylether sulphates, such as sodium lauryl ether sulphate (e.g. EMPICOL ESB70, available from Albright & Wilson).

Z0038~2 - 12 - J,3091 alkyl sulphonates, such as sodium alkane (C13-18) sulphonate (e.g. HOSTAPUR SAS 30, available from Hoechst).

olefin sulphonates, such as sodium olefin sulphonate S (C15-18) (e.g. HOSTAPUR OS,available from Hoechst).

Sarcosinates, having the structure (3):

R - C N - CH2COOM (3) where R3 is chosen from C6_14 alkyl, and M is a counterion chosen from alkali metals, ammonium, substituted ammonium, such as alkylolammonium.
An example of sarcosinates having the structure (3), sodium lauryl sarcosinate (e.g. HAMPOSYL L-95, available from Grace).
Taurides, having the structure (4):

R - C _ N (CH2)2s3M ~4) where R is chosen from C8 18 alkyl -- 13 - J,3091 An example of taurides having the structure (4) is:

coconut methyl taurine (e.g. FENOPON TC 42, available from GAF).

Isethionates, having the structure (5):

R - C - -- (CH2)2s3M (5) where R5 is chosen from C8_18 alkyl-An example of isethionates having the structure (5) is:
sodium acyl isethionate (e.g. JORDAPON Cl, available from Jordan).

Monoalkyl sulphosuccinates, having the structure (6):

o Il R O C- CH2CH COOM (6) I

where R6 is chosen from Cl0_20 alkyl-Examples of monoalkyl sulphosuccinates having this structure (6) include:

sodium lauryl sulphosuccinate (e.g. EMPICOL SLL, available from Albright & Wilson) magnesium alkyl sulphosuccinate (e.g. ELFANOL 616 Mg, available from AKZO), Z003l~4Z
- 14 - J,3091 sodium lauryl ethoxysulphosuccinate (e.g.
EMPICOL SDD, available from Albright & Wilson) coconut monoethanolamide ethoxysulphosuccinate, (e.g. EMPICOL SGG) disodium lauryl polyglycolether sulphosuccinate (e.g. SURTAGENE S30, available from CHEM-Y) polyethyleneglycol sulphosuccinate (e.g. REWOPOL
SBFA 30, available from REWO).

Dialkyl sulphosuccinates, having the structure (7):

R - O - C - CH2CH COOR8 (7) where R7 and R8 are the same or different, and are are chosen from C6 14 alkyl.
An example of dialkyl sulphosuccinate having the structure (7) is:

sodium dioctyl sulphosuccinate (e.g. EMCOL 4500 available from Witco).
- Acyl lactylates, having the structure (8):

O H O

30R -- C ~ (O~C - C)n OM (8) where R9 is chosen from C6_16 alkyl, and n is 1 or 2.

-- 15 - J,3091 An example of acyl lactylates having the structure (8) is:

decanoyl lactylate (e.g. PATIONIC 122A, available from Patterson, C.J.).

Acylated ~-amino acids, such as sodium lauroyl glutamate (e.g. ACYLGLUTAMATE LS-11, available from Ajinomoto Co. Inc.).
Ethyl carboxylates, such as alkyl C12 14(EO)4OCH2CO2Na (e.g. AKYPO RLM 38, available from AKZO).

Nonionic co-surfactants A composition according to the invention can also comprise nonionic co-surfactants which are compounds produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic compound, which may be aliphatic or alkyl aromatic in nature. Examples of nonionic co-surfactants include:

i. The polyethylene oxide condensates of alkyl phenols having from 6 to 12 carbon atoms, either straight or branched chain, with ethylene oxide, which is present in amounts of from 10 to 60 moles of ethylene oxide per mole of alkylphenol.

ii. The condensation product of aliphatic alcohols having from 8 to 18 carbon atoms, straight or branched chain, with ethyleneoxide, for example, a coconut alcohol ethyleneoxide condensate having from 10 to 13 moles of ethylene oxide per mole of coconut alcohol, 3~ the coconut alcohol fraction having from 10 to 14 carbon atoms.

- 16 - J,3091 iii. Long chain tertiary amineoxides having the structure (9):

Rl ORl lRl 2N--O ( g where R10 contains an alkyl, alkenyl or monohydroxyalkyl radical of from 8 to 18 carbon atoms, from 0 to 10 ethylene oxide moieties and from 0 to 1 glyceryl moiety, and Rll and R12 contain from 1 to 3 carbon atoms and up to 1 hydroxy group, for example, methyl, ethyl, propyl, hydroxyethyl, or hydroxypropyl groups.

Especially preferred examples of nonionic cosurfactants include:

alkylethoxylates, such as the DOBANOL series, available from Shell;

esterethoxylates, such as the TAGAT series, available from Goldschmidt;

alkylalkanolamides, such as coconut monoethanolamide (e.g.
~E~ILAN CME, available from Albright & Wilson), and 25 A co~onut diethanolomide, (e.g. EMPILAN CDE, available from Albright & Wilson).

sugar esters, such as sucrose laurate and methyl glucose laurate (available from Grillo-Werke A.G.) esters of glycols, such as ethylene glycol mono stearate.

esters of glycerol, such as glyceryl mono stearate.

ethoxylated sorbitan esters, such as the TWEEN series (available from ICI).
~ f~

200384~
-- 17 - J,3091 amine oxides, such as alkyldimethyl amine oxide (e.g.
EMPIGEN OB, available from Albright & Wilson) and alkylethoxydimethyl amine oxide (e.g. EMPIGEN oY, available from Albright & Wilson).

Zwitterionic and Amphoteric co-surfactants The composition according to the invention can also contain zwitterionic co-surfactants, which are derivatives of aliphatic quaternary ammonium, phosphonium and sulphonium compounds in which the aliphatic radicals can be straight or branched chain, and where one aliphatic substituent contains from 8 to 18 carbon atoms, and one contains an anionic water-solubilising group, such as carboxyl, sulphonate, sulphate, phosphate or phosphonate.

Examples of zwitterionic co-surfactant include:

4-[N,N-di(2-hydroxyethyl)-N-octadecylammonio]-butane-l-carboxylate
5-N,N-di(3-hydroxypropyl)-N-hexadecylammonio]-2-hydroxypentane-1-sulphate.

Particularly preferred zwitterionic co-surfactants are betaines, preferred examples of which are:

Alkyl betaines, having the structure (10):

R - N CH2C (10) where R16 is C10 16 alkyl.

-- 18 - J,3091 An example of alkyl betaines having the structure ~10) is:

lauryldimethyl betaine (e.g. EMPIGEN BB, available from Albright & Wilson).

Alkylamidopropyl betaines, having the structure (11):

ll H
(C 2)3 I C 2COO (11) 1~
where R 10-16yl.

An example of alkylamidopropyl betaines having the structure (11) is:

cocamidopropyl betaine (e.g. TEGOBETAIN L7, available from Goldschmidt).

Alkylamphoglycinates, and having the structure (12):

H

R and R are the same or different and are chosen from H, CH2COO and (CH2)2COO

An example of alkylamphoglycinates having the structure (12) is:

- 19 - J,3091 cocoamphoglycinate (available from GAF), and alkoamphodipropionate.

Sultaines, having the structure (13):
S

R21 N+ _ CH2- CH - CH2- SO3- (13) where R21 is chosen from C12 16 alkyl or alkylamido.

An example of sultaines having the structure (13) is:
A .
~cocoamidopropylhydroxysultaine (e.g. CYCLOTERIC
BET-CS, available from Alcolac).

Particularly preferred examples of amphoteric co-surfactants include:

Alkoamphoacetates, such as cocoamphoacetate (e.g.
~MIRANOL CM), and Alkoamphopropionates, such as cocoamphopropionate (e.g ~MIRANOL CM-SF) both available from Miranol Inc.

The amount of co-surfactant when present in the compositions according to the invention is usually up to 50%, preferably from 1 to 40~ by weight.

K

- 200~84Z
- 20 - J,3091 -Optional thickening agent The composition according to the invention can also comprise a polymer thickener in an amount sufficient to adjust the viscosity of the composition, so as to facilitate dispensing it conveniently onto the body surface.

Examples of polymer thickeners include:
anionic cellulose materials, such as sodium carboxy methyl cellulose;
anionic polymers such as carboxy vinyl polymers, for examples Carbomer 940 and 941;
nonionic cellulose materials, such a methyl cellulose and hydroxy propyl methyl cellulose;
cationic cellulose materials, such as Polymer JR 400;
cationic gum materials, such as Jaguar C13 S;
other gum materials such as gum acacia, gum tragacanth, locust bean gum, guar gum and carrageenan;
proteins, such as albumin and protein hydrolysates;
and clay materials, such as bentonite, hectorite, magnesium aluminium silicate, sodium magnesium silicate and a synthetic complex clay having the generic formula:
[Si M Li H o ]0 6-Laponite, available from Laporte Industries.

The amount of thickening agent which can optionally be employed in the composition according to the invention is normally from 0.05 to 5%, preferably 0.1 to 1% by weight of the composition.

Z00384~
-- 21 - J,3091 Preservative The composition according to the invention can also optionally comprise a preservative to prevent microbial spoilage, especially biodegradation of the alkyl phosphate salt. It is accordingly apparent that the composition containing the alkyl phosphate salt may be prone to attack by bacteria, moulds and fungi and other microbial influences. There is therefore a risk that the shelf-life of the composition might be unacceptably short due to the biodegradation or spoilage, unless there is included in the composition a bactericide, fungicide or other microbicide in an amount sufficient to inhibit or prevent the said biodegradation or spoilage, or unless other steps are taken to preserve the composition.

Examples of preservatives include:

(i) Chemical preservatives, such as ethanol, benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, sodium propionate and the methyl, ethyl, propyl and butyl esters of p-hydroxybenzoic acid 2-bromo-2-nitropropane-1,3-diol, phenoxyethanol, dibromodicyanobutane, formalin and Triclosan. The amount of chemical preservative optionally to be incorporated in the composition according to the invention will generally be from 0.05 to 5%, preferably from 0.1 to 2% by weight, the amount chosen being sufficient to arrest microbial proliferation.
(ii) Water activity depressants, such as glycerol, propylene glycol, sorbitol, sugars and salts, for examples alkali metal halides, sulphates and carboxylates. When employing a water activity depressant, sufficient should be incorporated in the composition according to the invention to reduce the water activity (~w) from 1 to 20038a~2 - 22 - J,3091 <0.9, preferably to <0.85 and most preferably < 0.8, the lowest of these values being that at which yeasts, moulds and fungi will not proliferate.

Further optional ingredients The composition according to the invention can also contain other optional adjuncts, that is ingredients other than the main ingredients already defined which are conventionally employed in compositions for topical application to human skin. These adjuncts, when present, will normally form the balance of the composition.

Examples of optional adjuncts include vehicles, the selection of which will depend on the required product form of the composition. Typically, the vehicle when present, will be chosen from diluents, dispersants or carriers for the dialkyl or dialkenyl phosphate salt so as to ensure an even distribution of it when applied to the skin.

Compositions according to this invention can include water as a vehicle, usually with at least one other cosmetically-acceptable vehicle.
Vehicles other than water that can be used in compositions according to the invention can include liquids or solids as emollients, solvents, humectants, thickeners and powders. Examples of each of these types of vehicles, which can be used singly or as mixtures of one or more vehicles, are as follows:

Emollients, such as stearyl alcohol, glyceryl monolaurate, glyceryl monoricinoleate, glyceryl monostearate, propane-1,2-diol, butane-1,3-diol, docosan-1,2-diol, mink oil, cetyl alcohol, isopropyl 20038~Z
- 23 - J,3091 isostearate, stearic acid, isobutyl palmitate, isocetyl ~ stearate, oleyl alcohol, isopropyl laurate, hexyl laurate, decyl oleate, octadecan-2-ol, isocetyl alcohol, eicosanyl alcohol, behenyl alcohol, cetyl palmitate, silicone oils such as dimethylpolysiloxane, di-n-butyl sebacate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, butyl stearate, polythylene glycol, triethylene glycol, lanolin, cocoa butter, corn oil, cotton seed oil, tallow, lard, olive oil, palm kernel oil, rapeseed oil, safflower seed oil, soybean oil, sunflower seed oil, olive oil, sesame seed oil, coconut oil, arachis oil, castor oil, acetylated lanolin alcohols, petroleum, mineral oil, butyl myristate, isostearic acid, palmitic acid, isopropyl linoleate, lauryl lactate, myristyl lactate, decyl oleate, myristyl myristate;

Propellants, such as trichlorofluoromethane, dichlorodifluoromethane, dichlorotetrafluoroethane, monochlorodifluoromethane, trichlorotrifluoroethane, propane, butane, isobutane, dimethyl ether, carbon dioxide, nitrous oxide;

Solvents, such as ethyl alcohol, methylene chloride, isopropanol, acetone, castor oil, ethylene glycol monoethyl ether, diethylene glycol monobutyl ether, diethylene glycol monoethyl ether, dimethyl sulphoxide, dimethyl formamide, tetrahydrofuran;

Humectants, such as glycerin, sorbitol, sodium 2-pyrrolidone-5-carboxylate, soluble collagen, dibutyl phthalate, gelatin;

Powders, such as chalk, talc, fullers earth, kaolin, starch, gums, colloidal silicon dioxide, sodium polyacrylate, tetra alkyl and/or trialkyl aryl ammonium 20()3~
-- 24 - J,3091 smectites, chemically modified magnesium aluminium silicate, organically modified montmorillonite clay, hydrated aluminium silicate, fumed silica, carboxyvinyl polymer, sodium carboxymethyl cellulose, ethylene glycol monostearate.

The cosmetically acceptable vehicle, when present, will usually form from 0.01 to 99.9~, preferably from 50 to 98% by weight of the composition, and can, in the absence of other cosmetic adjuncts, form the balance of the composition.

PRODUCT FORM OF THE COMPOSITION

The composition according to the invention can take the form of a liquid or gel, intended to be dispensed from a capped container such as a bottle, roll-on applicator or tube, or a pump-operated or propellant-driven aerosol dispenser, as a skin cleanser, shower product, bath additive or shampoo. The composition can also take for form of a powder or a solid such as a stick, preferably housed in a suitable capped holder with a wind-up or push-up action similar to a lip stick, or a bar or tablet, with or without fatty acid soaps, intended to be used for washing instead of a conventional soap bar.

The invention also provides a closed container containing a detergent composition as herein defined.

Process for Preparing the Composition The invention also provides a process for preparing the composition of the type defined herein, which process comprises the steps of:

- 25 - J,3091 (i) preparing a mixture comprising one or more dialkyl ~ and/or dialkenyl phosphate salts, as defined herein, and one or more monoalkyl and/or monoalkenyl phosphate salts as defined herein, and (ii) subsequently packaging the mixture into containers.

Use of the composition The composition according to the invention is intended primarily as a personal washing product for cleansing the face and other sensitive parts of the body surface, including the mucosae. It can also be used for washing the hair as well as the skin.
In use, a small quantity, for example from 1 to 5 ml, of the composition is either rubbed between the hands, together with water to form a foam, which is then used for washing, or applied via a flannel or sponge to the area to be cleansed, or the foam is generated directly on that area. The foam is subsequently rinsed away with clean water.

EVIDENCE TO SHOW ENHANCED LATHER PROPERTIES
Experiments were performed to demonstrate how lather volume obtainable with dioctyl phosphate salt increases with decreasing levels of monooctyl phosphate salt in compositions according to the invention.
Foam was generated in a standard manner using a Foam Machine whose construction and use will now be described.

- 26 - J,3091 The Foam Machine -Foam is generated within a glass graduated cylinder by the action of a perforated piston upon the test composition and a suitably treated substrate. The repetitive compression and expansion of the substrate by the piston results in the aeration of the composition and the generation of foam which accumulates above the piston plate. The volume of the foam can then be read using the graduations of the cylinder when the piston is at its lowest point. The apparatus is enclosed and is supplied with air at a constant temperature of 38C.

The operation of the machine in detail is as follows.
î5 Crimped nylon fibre is soaked in a large quantity of a solution of 2.5% by weight artificial sebum, consisting of squalene, cholesterol, long chain fatty acids, long chain triglycerides and decyl oleate, in dichloromethane for 1 hour. The solvent is poured away, and the fibres are dried by evaporation of residual solvent. The sebum-treated nylon fibre is intended to simulate greasy human skin or hair to which the composition of the invention would normally be applied when washing the skin or shampooing the hair.
Into a graduated glass cylinder of internal diameter 3.8cm are placed two discs of polyurethane foam (diameter 3.8cm, height l.Ocm). 2g of sebum-treated fibre is placed on top of the foam and the diluted test composition (2 ml) is poured over. The diluted composition is prepared from 7.5g of test composition and 92.5g of distilled water.

The prepared cylinder is placed within the foam machine, and with the cross-head at its lowest point the piston plate is adjusted to a level of 70 ml (as determined from the graduations on the cylinder).

._ - 27 - J,3091 The machine is operated with a periodicity of 12 rpm.
After each minute of operation, the machine is stopped with the cross-head at the highest point and the volume of foam above the piston plate is recorded.

The machine is operated for a total of 10 minutes, the reported value is the mean of the foam volume values recorded between 3 and 10 minutes inclusive.

Foam Volume Results All foam values for the dialkyl phosphate were recorded for the triethanolamine salt at pH 8. The percentage surfactant in the composition is based on the weight of the dialkyl phosphate in the acid form, not as the salt.

The following table shows the Foam Volumes obtainable from an aqueous solution containing dioctyl phosphate ~DOP) and monooctyl phosphate (MOP) at a range of values.

DOP (% w/w)MOP (% w/w) Foam Volume (ml) 0 54.3 19 1 38.9 18 2 26.3 17 3 29.4 From these results, it can be seen that the foam volume is enhanced with decreasing levels of monooctyl phosphate in relation to the amounts of dioctyl phosphate present. Preferably the weight ratio of monooctyl phosphate to dioctyl phosphate should not exceed 3:17.

- 28 - J,3091 EXAMPLES

The invention is further illustrated by reference to the following examples.

Example 1 This Example illustrates a body cleansing liquid product suitable for use in the shower.
The product contains the following ingredients:

Ingredients % w/w triethanolamine di-n-octyl phosphate 36 triethanolamine mono-n-octyl phosphate 0.1 preservative 2 water to 100 This product can be used for cleansing the whole body surface, including the hair, for example under the shower, a convenient amount of say 5ml being placed in the palm of the hand prior to distributing over the body surface with added water to create a lather with superior volume and creaminess characteristics.

- 29 - J,3091 Examples 2 to 8 illustrate body shampoos for use in the shower or when bathing.

Example 2 % w/w triethanolammonium di-n-octyl phosphate 36 triethanolammonium mono-n-octyl phosphate 0.2 triethanolammonium laurate 10 triethanolammonium myristate 2 alkyldialkylamine oxide (EMPIGEN OB:
30% active 8.3 cationised cellulose 0.1 propylene glycol 10 15 water to 100 Example 3 % w/w triethanolammonium di-n-octyl phosphate 24 triethanolammonium mono-n-octyl phosphate 0.2 lauryl dimethylbetaine 3 ethylene glycol monostearate 1.5 25 propylene glycol 2.5 preservative, perfume, dyes q.v.
water to 100%

~ 30 - J,3091 Example 4 % w/w sodium di-(diethyleneglycol-mono-n-nonyl ether) phosphate 30 sodium mono-diethyleneglycol-mono-n-nonyl ether) phosphate 0.4 triethanolammonium laurate 10 triethanolammonium myristate 2 alkyldialkylamine oxide (EMIGEN OB:
30% active) 8.3 cationised cellulose 0.1 propylene glycol 10 15 water to 100 Example 5 % w/w triethanolammonium di-(ethyleneglycol -mono-n-octyl ether) phosphate 20 triethanolammonium mono-(ethyleneglycol -mono-n-octyl ether) phosphate 2 25 lauryl dimethylbetaine 3 ethylene glycol monostearate 1.5 propylene glycol 2.5 preservative, perfume, dyes q.v.
water to 100 - 31 - J,3091 Example 6 % w/w 5 triethanolammoniumdi-(ethyleneglycol -mono-n-heptyl ether~phosphate 30 triethanolammonium mono-(ethyleneglycol -n-heptyl ether) phosphate 0.2 triethanolammonium laurate 10 triethanolammonium myristate 2 alkyldialkylamine oxide (EMIGEN OB:
30% active) 8.3 cationised cellulose 0.1 propylene glycol 10 15 water to 100 Example 7 % w/w sodium di-(7-methyloctyl) phosphate 25 sodium mono~7-methylocty~ phosphate 0.3 lauryl dimethylbetaine 3 ethylene glycol monostearate 1.5 25 propylene glycol 2.5 preservative, perfume, dyes q.v.
water to 100%

Z0038~2 - 32 - J,3091 % w/w Example 8 sodium di-(di-ethyleneglycol-mono-n-nonyl ether) phosphate 25 sodium mono-(ethyleneglycol-mono-n-nonyl ether) phosphate 0.5 cocoamidopropyl betaine 5 preservatives, perfumes, dyes q.v.
10 water to 100 Examples 9 to 16 illustrate hair shampoos.

% w/w Example 9 triethanolammonium di-n-heptyl phosphate 20 triethanolammonium mono-n-heptyl phosphate 0.5 20 cocamidopropyl betaine 1.5 preservatives, dyes, perfumes q.v.
water to 100%

Example 10 triethanolammonium di-n-nonyl phosphate 10 disodium lauryl sulphosuccinate 4 cocamidopropyl betaine 4 triethanolammonium mono-n-nonyl phosphate 0.8 30 preservatives, dyes, perfumes q.v.
water to 100%

._ - 33 - J,3091 % w/w Example 11 triethanolammonium di-n-heptenyl phosphate 20 triethanolammonium mono-n-heptenyl phosphate 0.5 cocamidopropyl betaine 1.5 preservatives, dyes, perfumes q.v.
water to 100%
Example 12 % w/w 15 triethanolammonium di-n-nonenyl phosphate 10 triethanolammonium mono-n-nonenyl phosphate 0.8 disodium lauryl sulphosuccinate 4 cocamidopropyl betaine 4 preservatives, dyes, perfumes q.v.
20 water to 100%

% w/w Example 13 potassium di-(5-methylhexyl) phosphate 25 potassium mono-(5-methylhexyl) phosphate 0.5 cocamidopropyl betaine 1.5 preservatives, dyes, perfumes q.v.
30 water to 100 - 34 - J,3091 Example 14 triethanolammonium di-(6,6-dimethylheptyl) phosphate 10 5 disodium lauryl sulphosuccinate 4 cocamidopropyl betaine 4 triethanolammonium mono-(6,6-dimethylheptyl) phosphate preservatives, dyes, perfumes q.v.
10 water to 100%

Example 15 % w/w 15 triethanolammonium di-octenyl phosphate 15 triethanolammonium mono-octenyl phosphate 0.3 lauryldimethyl betaine 6 preservatives, perfumes, dyes q.v.
water to 100 Example 16 % w/w triethanolammonium di-(7-methyloctyl) phosphate 25 triethanolammonium mono-(7-methyloctyl) phosphate 0.4 preservatives, perfumes, dyes q.v.
water to 100 - ~003B4~
~ 35 - J,3091 Examples 17 to 21 illustrate facial foaming cleansers.

% w/w Example 17 sodium di-n-octylphosphate 30 sodium mono-n-octyl phosphate 0.6 lauryl dimethyl betaine 4 10 sorbitol 5 glycerol 2 quaternised cellulosic polymer (Polymer JR400) 0.3 preservative, dyes, perfumes q.v.
15 water to 100 % w/w Example 18 20 sodium di-(triethyleneglycol-mono-n-octenyl ether) phosphate 25 sodium mono-(triethyleneglycol-n-octenyl ether) phosphate 0.5 lauryl dimethyl betaine 4 25 sorbitol 5 glycerol 2 quaternised cellulosic polymer (Polymer JR400) 0.3 preservative, dyes, perfumes q.v.
30 water to 100 - 36 - J,3091 % w/w Example 19 sodium di-n-octyl phosphate 30 5 sodium mono-n-octyl phosphate 0.6 lauryl dimethyl betaine 4 sorbitol 5 glycerol 2 quaternised cellulosic polymer (Polymer JR400) 0.3 preservative, dyes, perfumes a.v.
water to 100 % w/w lS Example 20 sodium di-n-octylphosphate 15 sodium di-n-nonylphosphate 10 sodium mono-n-octyl phosphate 0.1 20 sodium mono-n-nonyl phosphate 0.1 sorbitol 3 preservatives, perfume, dyes q.v.
water to 100%

25 Example 21 sodium di-(diethyleneglycol-mono-n-octyl ether) phosphate 30 sodium mono-(diethyleneglycol-mono-n-octyl ether) phosphate 0.8 sorbitol 6 propylene glycol 2 preservatives, perfumes, dyes q.v.
water to 100 .
- 37 - J,3091 Examples 22, 23 & 24 The following three examples illustrate soap-containing products with di-n-octyl phosphate salt and mono-n-octyl phosphate in accordance with the invention.

In each case, the products were made in accordance with standard soap manufacture. The product of Example 22 yielded a flaked product which could not readily be pressed into a bar, as the flakes were not sufficiently cohesive. With the products of Examples 23 and 24 bars were formed following the usual plodding, extrusion and stamping that is conventional in soap bar manufacture.
These soap products had the following formulations:

Examples Ingredient 22 23 24 (% by weight) Hardened Tallow Soap 64 66.6 80/20 tallow-coco soap - 9 76 sodium di-n-octyl phosphate 15.8 14.3 18.8 sodium mono-n-octyl phosphate 0.2 0.1 0.2 water 20 10 5

Claims (23)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A composition suitable for topical application to the skin or hair, which comprises:

a. from 1 to 99.9% by weight of a dialkyl or dialkenyl phosphate salt (or mixtures thereof) having the structure (1):

(1) b. from 0.01 to 20% by weight of a monoalkyl or monoalkenyl phosphate salt (or mixtures thereof) having the structure (2):

( 2 ) where R01, R02 and R03 are each chosen from branched or unbranched, alkyl or alkenyl groups having an average of from 7 to 9 carbon atoms;

X, Y and Z are each chosen from H, alkali metal, ammonium and substituted ammonium counterions; and a, b and c are each chosen from 0 or a value of from 1 to 4;

the weight ratio of the monoalkyl or monoalkenyl phosphate salt to the dialkyl or dialkenyl phosphate salt being from 1:1000 to 1:5.
2. A composition according to claim 1, in which the dialkyl phosphate moiety of the alkyl phosphate salt is chosen from:

di-n-heptyl phosphate di-n-octyl phosphate di-n-nonyl phosphate di-(7-methyloctyl) phosphate di-(5-methylhexyl) phosphate di-(6,6-dimethylheptyl) phosphate di-(ethyleneglycol-mono-n-octyl ether) phosphate di-(ethyleneglycol-mono-n-heptyl ether) phosphate di-(diethyleneglycol-mono-n-octyl ether) phosphate n-hexyl-n-nonyl phosphate, and n-hexyl-n-octyl phosphate.
3. A composition according to claim 1, in which the dialkenyl phosphate moiety of the alkenyl phosphate salt is chosen from:

di-n-heptenyl phosphate di-n-octenyl phosphate di-n-nonenyl phosphate, and di-(triethyleneglycol-mono-n-octenyl ether) phosphate
4. A composition according to claim 1 or 2, in which the dialkyl phosphate salt is a dioctyl phosphate salt.
5. A composition according to claim 1, 2 or 3, in which the monoalkyl phosphate moiety of the monoalkyl phosphate salt is chosen from:

mono-n-heptyl phosphate mono-n-octyl phosphate mono-n-nonyl phosphate diethyleneglycol-mono-n-nonyl ether phosphate ethyleneglycol-mono-n-octyl ether phosphate mono-7-methyloctyl phosphate, and mono-6,6-dimethylheptyl phosphate
6. A composition according to claim 1, 2 or 3 in which the monoalkenyl phosphate moiety of the monoalkenyl phosphate salt is chosen from:

mono-n-heptenyl phosphate mono-n-octenyl phosphate mono-n-nonenyl phosphate, and triethyleneglycol-mono-n-octenyl ether phosphate
7. A composition according to claim 1, 2 or 3 in which the monoalkenyl phosphate salt is a mono-n-octenyl phosphate salt.
8. A composition according to claim 1, 2 or 3, in which the counterion is chosen from sodium, potassium or triethanolammonium.
9. A composition according to claim 1, 2 or 3, in which the dialkyl or dialkenyl phosphate salt forms from 2 to 50% by weight of the composition.
10. A composition according to claim 1, 2 or 3, in which the monoalkyl or monoalkenyl phosphate salt forms from 0.05 to 5% by weight of the composition.
ll. A composition according to claim 1, 2 or 3, in which the alkyl group of the monoalkyl or monoalkenyl phosphate salt has the same number of carbon atoms as that of the dialkyl or dialkenyl group of the phosphate salt.
12. A composition according to claim 1, 2 or 3, in which the weight ratio of the monoalkyl or monoalkenyl phosphate salt to the dialkyl or dialkenyl phosphate salt is from 1:1000 to 1:20.
13. A composition according to claim 1, 2 or 3, which further comprises an anionic co-surfactant.
14. A composition according to claim l, 2 or 3, which further comprises a nonionic co-surfactant.
15. A composition according to claim 1, 2 or 3, which further comprises a zwitterionic co-surfactant.
16. A composition according to claim 1, 2 or 3, which is a liquid or gel product.
17. A composition according to claim 1, 2 or 3 which is a washing product suitable for topical application to the face.
18. A composition according to claim 1, 2 or 3, which is a shampoo.
l9. A composition according to claim 1, 2 or 3, which is a powder.
20. A composition according to claim 1, 2 or 3, which is a bar or tablet suitable for washing the skin.
21. A composition according to claim 1, 2 or 3, which is a soap bar or soap tablet.
22. A process for preparing a composition according to claim 1, 2 or 3, which process comprises the steps of:

i. preparing a mixture comprising:

a. one or more dialkyl or dialkenyl phosphate salts having the structure (1):

( 1 ) b. one or more monoalkyl or monoalkenyl phosphate salts having the structure (2):

( 2) where R01, R02 and R03 are each chosen from branched or unbranched, alkyl or alkenyl groups having an average of from 7 to 9 carbon atoms; and X, Y and Z are each chosen from H, alkali metal, ammonium, substituted ammonium counterions; and a, b and c are each chosen from 0, or a value of from 1 to 4;

the weight ratio of the monoalkyl or monoalkenyl phosphate salt to the dialkyl or dialkenyl phosphate salt being from 1:1000 to 1:5, and ii. subsequently packaging the composition so formed into containers.
23. The use of a composition according to claim 1, 2 or 3, for washing human skin or hair.
CA002003842A 1988-12-01 1989-11-24 Topical composition Expired - Fee Related CA2003842C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888828013A GB8828013D0 (en) 1988-12-01 1988-12-01 Topical composition
GB8828013.6 1988-12-01

Publications (2)

Publication Number Publication Date
CA2003842A1 CA2003842A1 (en) 1990-06-01
CA2003842C true CA2003842C (en) 1995-08-08

Family

ID=10647758

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002003842A Expired - Fee Related CA2003842C (en) 1988-12-01 1989-11-24 Topical composition

Country Status (12)

Country Link
US (1) US5015471A (en)
EP (1) EP0371802B1 (en)
JP (1) JPH02200616A (en)
KR (1) KR940001003B1 (en)
AT (1) ATE82116T1 (en)
AU (1) AU629263B2 (en)
BR (1) BR8906119A (en)
CA (1) CA2003842C (en)
DE (1) DE68903473T2 (en)
ES (1) ES2054032T3 (en)
GB (1) GB8828013D0 (en)
ZA (1) ZA899197B (en)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000704D0 (en) * 1990-01-12 1990-03-14 Unilever Plc Topical composition
GB9003199D0 (en) * 1990-02-13 1990-04-11 Unilever Plc Topical composition
US5211941A (en) * 1990-06-11 1993-05-18 Kao Corporation Hair cleansing composition
US5670160A (en) * 1990-08-24 1997-09-23 Schulke & Mayr Gmbh Preservatives and their use
GB9101850D0 (en) * 1991-01-29 1991-03-13 Du Pont Howson Ltd Improvements in or relating to printing
GB9204175D0 (en) * 1992-02-27 1992-04-08 Unilever Plc Cleansing composition
US5264045A (en) * 1992-06-04 1993-11-23 Alfred Zofchak Method for cleaning mechanical surfaces covered with grease, oil and other sticky materials
JP2736486B2 (en) * 1992-07-03 1998-04-02 花王株式会社 Cleansing composition
US5597406A (en) * 1993-11-02 1997-01-28 Henkel Corporation Method of thickening aqueous formulations
US5501813A (en) * 1993-11-02 1996-03-26 Henkel Corporation Thickener for aqueous compositions
GB9323306D0 (en) * 1993-11-11 1994-01-05 Procter & Gamble Cleansing compositions
DE69624799T2 (en) * 1995-03-14 2003-07-17 Procter & Gamble DISPERSED SMEKTIT TONE AS AN OIL-IN-WATER STABILIZER FOR LIQUID SKIN CLEANSING COMPOSITION
ATE212217T1 (en) * 1995-03-14 2002-02-15 Procter & Gamble DISPERSED AMORPHOUS SILICIC ACID AS OIL-IN-WATER STABILIZER FOR LIQUID SKIN CLEANING COMPOSITION
US5605676A (en) * 1995-06-26 1997-02-25 Colgate-Palmolive Company Oral composition exhibiting improved uptake and retention of antibacterial compounds on dental tissue surfaces
EP0839023B1 (en) * 1995-08-07 2003-04-09 Unilever Plc Liquid cleansing composition comprising soluble, lamellar phase inducing structurant
HUP0000094A3 (en) * 1996-09-24 2001-05-28 Unilever Nv Liquid cleansing compositions comprising stability enhancing surfactants and a method of enhancing low temperature stability thereof
US5800803A (en) * 1997-02-10 1998-09-01 Colgate-Palmolive Company Oral composition exhibiting enhanced uptake by dental tissue of noncationic antibacterial agents
FR2781368B1 (en) * 1998-07-27 2000-09-01 Oreal COMPOSITION CONTAINING AN OPACIFYING OR NACRANT AGENT AND AT LEAST ONE FATTY ALCOHOL
US6262130B1 (en) * 1998-11-24 2001-07-17 Rhodia, Inc. High solids, pumpable aqueous compositions of high monoalkyl phosphate ester salt content
US6217913B1 (en) * 1999-07-15 2001-04-17 Fatemeh Mohammadi Cosmetic compositions with gorgonian extract
JP3908420B2 (en) * 1999-10-12 2007-04-25 花王株式会社 Cleaning composition
US6673358B1 (en) 1999-12-16 2004-01-06 Kimberly-Clark Worldwide, Inc. Wet wipes containing a mono alkyl phosphate
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US6946413B2 (en) 2000-12-29 2005-09-20 Kimberly-Clark Worldwide, Inc. Composite material with cloth-like feel
US20020132543A1 (en) 2001-01-03 2002-09-19 Baer David J. Stretchable composite sheet for adding softness and texture
US6610314B2 (en) 2001-03-12 2003-08-26 Kimberly-Clark Worldwide, Inc. Antimicrobial formulations
US7176150B2 (en) 2001-10-09 2007-02-13 Kimberly-Clark Worldwide, Inc. Internally tufted laminates
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
EP1556009B2 (en) * 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8808671B2 (en) * 2005-08-29 2014-08-19 Rutgers, The State University Of New Jersey Non-tumorigenic ointment/cream base for topical application
JP4663540B2 (en) * 2006-02-07 2011-04-06 花王株式会社 Hair treatment agent
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
MX366869B (en) * 2013-03-15 2019-07-29 Hercules Inc Composition and method of producing personal care compositions with improved deposition properties.
CN104758243B (en) * 2015-04-01 2017-04-12 山东司邦得制药有限公司 Montmorillonite external-application ointment for treating skin ulcer and preparation method and application thereof
MX2020012139A (en) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Compositions and methods for treating rosacea and acne.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2758093A (en) * 1948-06-22 1956-08-07 Textilana Corp Laundering compositions containing ortho-phosphoric acid esters
JPS5326806A (en) * 1976-08-24 1978-03-13 Kao Corp Low irritating detergent composition
JPS6056121B2 (en) * 1978-12-05 1985-12-09 花王株式会社 liquid hair conditioner composition
US4298494A (en) * 1979-03-27 1981-11-03 Lever Brothers Company Shampoo
JPS5874798A (en) * 1981-10-28 1983-05-06 花王株式会社 Shampoo composition
JPS5943517B2 (en) * 1981-12-14 1984-10-22 花王株式会社 liquid cleaning composition
JPS6159602A (en) * 1984-08-29 1986-03-27 Matsushita Electric Ind Co Ltd Record player
JPS6191137A (en) * 1984-10-11 1986-05-09 Kao Corp External drug composition
ES2026844T3 (en) * 1985-11-28 1992-05-16 Kao Corporation A DETERGENT COMPOSITION.
JPS62127399A (en) * 1985-11-28 1987-06-09 花王株式会社 Detergent composition
JPS62132811A (en) * 1985-12-02 1987-06-16 Kao Corp Shampoo composition
JPS62138593A (en) * 1985-12-12 1987-06-22 花王株式会社 Detergent composition
JPH0246639B2 (en) * 1985-12-12 1990-10-16 Kao Corp SENJOZAISOSEIBUTSU
WO1989001023A1 (en) * 1987-08-03 1989-02-09 Interface Research Corporation Microbiocidal cleansing or disinfecting formulations and preparation thereof

Also Published As

Publication number Publication date
ES2054032T3 (en) 1994-08-01
AU629263B2 (en) 1992-10-01
DE68903473T2 (en) 1993-05-06
JPH0460573B2 (en) 1992-09-28
EP0371802A1 (en) 1990-06-06
EP0371802B1 (en) 1992-11-11
GB8828013D0 (en) 1989-01-05
ZA899197B (en) 1991-08-28
CA2003842A1 (en) 1990-06-01
US5015471A (en) 1991-05-14
KR900009054A (en) 1990-07-02
JPH02200616A (en) 1990-08-08
KR940001003B1 (en) 1994-02-08
DE68903473D1 (en) 1992-12-17
ATE82116T1 (en) 1992-11-15
AU4558189A (en) 1990-06-07
BR8906119A (en) 1990-07-31

Similar Documents

Publication Publication Date Title
CA2003842C (en) Topical composition
CA2003839C (en) Topical composition
EP0442701B1 (en) Topical composition
CA2003841C (en) Topical composition
CA2003843C (en) Topical composition
US4726915A (en) Detergent compositions
US6322799B1 (en) Benefit agent compositions comprising mixtures of α-hydroxy esters
EP1029532B1 (en) Liquid cleansing composition
EP0437347B1 (en) Topical composition
WO1995005154A1 (en) Cleansing composition
MXPA99011655A (en) Benefit agent compositions comprising mixtures of alpha-hydroxy esters
MXPA99006937A (en) Method for removing make-up from skin

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed